Laboratory Services - Membrane Proteome Array Screening for Novel Monoclonal Antibody... Tender

Procurement Summary

Country: USA

Summary: Laboratory Services - Membrane Proteome Array Screening for Novel Monoclonal Antibody target identification.

Deadline: 21 Aug 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 124461817

Document Ref. No.: 75N94025Q00186

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation number is 75N94025Q00186 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2025-05. The North American Industry Classification (NAICS) Code is 514380 and the business size standard is $19m. However, this solicitation is not set aside for small business. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to contract on a sole source basis with Integral Molecular Inc. of Philadelphia, PA Instruments America Inc., laboratory services for Membrane Proteome Array Screening for novel monoclonal antibody target identification.

SCOPE OF WORK/TASKSIntegral Molecular shall perform Membrane Proteome Array (MPA) screening services and a Secreted Proteome Library (SPL) to identify binding targets for monoclonal antibodies provided by the Unit on Skeletal Genomics, Division of Translational Medicine, NICHD. The monoclonal antibodies were already expressed recombinantly, based on sequences obtained from patients over the course of the last several months. The contractor will use its proprietary live-cell, flow cytometry-based platform to screen each antibody against a panel of over 6, 000 native human membrane proteins.The following tasks are required:• Receive and qualify monoclonal antibody samples.

• Perform MPA screening against full-length human membrane proteins.

• Analyze binding specificity and identify targets.

• Provide a summary report of results in electronic format...
Active Contract Opportunity
Notice ID : 75N94025Q00186
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NICHD
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Aug 13, 2025 10:32 pm EDT
Original Date Offers Due: Aug 21, 2025 05:00 pm EDT
Inactive Policy: Manual
Original Inactive Date: Aug 22, 2025
Initiative: None

Classification
Original Set Aside: No Set aside used
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice